BANK VONTOBEL/CALL/ROCHE GS/300/0.02/20.12.24 Share Price

Warrant

WROBLV

CH1225162978

Real-time Bid/Ask 03:17:28 17/05/2024 pm IST
0.026 CHF / 0.036 CHF +19.23% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/300/0.02/20.12.24
6 months-50.00%
Current year-48.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
16/24/16 0.026 +30.00%

Delayed Quote Swiss Exchange

Last update May 16, 2024 at 08:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROBLV
ISINCH1225162978
Date issued 22/11/2022
Strike 300 CHF
Maturity 20/12/2024 (217 Days)
Parity 50 : 1
Emission price 0.66 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.73 CHF
Lowest since issue 0.02 CHF
Delta0.09x
Omega 14.18
Premium27.34x
Gearing152.77x
Moneyness 0.7893
Difference Strike 63.25 CHF
Difference Strike %+21.08%
Spread 0.01 CHF
Spread %27.78%
Theoretical value 0.0310
Implied Volatility 20.95 %
Total Loss Probability 93.13 %
Intrinsic value 0.000000
Present value 0.0310
Break even 301.55 CHF
Theta-0x
Vega0.01x
Rho0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
234.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+18.99%
Consensus
  1. Stock Market
  2. Warrants
  3. WROBLV Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW